Diabetes drug shows promise for weight loss

Injectable liraglutide may be suitable for use as a weight loss therapy in obese patients without diabetes.

When used as an adjunct to diet and exercise, the long-acting glucagon-like peptide-1 receptor agonist results in clinically meaningful benefits compared with diet and exercise alone, according to the results of a 56-week international trial.